Nonreplicating Vaccines Can Protect African Green Monkeys From the Memphis 37 Strain of Respiratory Syncytial Virus

Role of Neutralizing Antibodies in Adults With Community-Acquired Pneumonia by Respiratory Syncytial Virus

(2012) V. Luchsinger et al.   CLINICAL INFECTIOUS DISEASES

Vaccination with Cancer- and HIV Infection-Associated Endogenous Retrotransposable Elements Is Safe and Immunogenic

(2012) J. B. Sacha et al.   JOURNAL OF IMMUNOLOGY

CpG DNA as a vaccine adjuvant

(2011) Christian Bode et al.   Expert Review of Vaccines

Respiratory Syncytial Virus Infection in Adults

(2011) Edward Walsh   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Viral Load Drives Disease in Humans Experimentally Infected with Respiratory Syncytial Virus

(2010) John P. DeVincenzo et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

GM-CSF Increases Mucosal and Systemic Immunogenicity of an H1N1 Influenza DNA Vaccine Administered into the Epidermis of Non-Human Primates

(2010) Peter T. Loudon et al.   PLoS One

Development of prophylactic and therapeutic vaccines using the ISCOMATRIX adjuvant

(2009) Eugene Maraskovsky et al.   IMMUNOLOGY AND CELL BIOLOGY

Refined methods for propagating vesicular stomatitis virus vectors that are defective for G protein expression

(2009) Susan E. Witko et al.   JOURNAL OF VIROLOGICAL METHODS

A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults ≥65 years of age

(2009) Joanne M. Langley et al.   VACCINE

Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus (RSV) Vaccines— Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum—Given Concomitantly with Influenza Vaccine to High‐Risk Elderly Individuals

(2008) Ann R. Falsey et al.   JOURNAL OF INFECTIOUS DISEASES